Is GNTA or GRCE more undervalued in 2026?

CirclFi compares Genenta Science S.p.A. (GNTA) and Grace Therapeutics, Inc. (GRCE) using 13 institutional-grade valuation models. GNTA has a Quality of Company score of 4.7/10 while GRCE scores 4.6/10.

Which is a better buy — GNTA or GRCE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GNTA and GRCE valuations compare?

GNTA at $0.90 and GRCE at $2.43 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GNTA vs GRCE Valuation Comparison 2026 — Intrinsic Value Analysis

GNTA

Biotechnology

Genenta Science S.p.A.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$0.90

Last close

Models

7/13

Active

GRCE

Biotechnology

Grace Therapeutics, Inc.

Quality

4.6

out of 10

Value Trap

WARN

Price

$2.43

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	GNTA Fair Value	GNTA Upside	GRCE Fair Value	GRCE Upside
Bayesian DCF	Intrinsic	$0.30	-66.6%	$1.31	-46.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.05	-92.7%	$4.05	+66.7%
Dynamic NAV	Asset-Based	$0.80	-11.1%	$3.38	+39.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GNTA vs GRCE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GNTA vs GRCE — Which Stock Is More Undervalued?

GNTA scores higher with a 4.7/10 quality rating vs GRCE's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Genenta Science S.p.A. (GNTA) and Grace Therapeutics, Inc. (GRCE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GNTA currently trades at $0.90 with a QOC of 4.7/10, while GRCE trades at $2.43 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).